{"session_id": 54, "bill_id": 18282, "bill_type": "House Bill", "bill_number": 1277, "bill_title": "create a pharmaceutical prior authorization program for eligible individuals receiving medicaid.", "sponsors": [{"legislator_profile_id": 2840, "is_prime": true}, {"legislator_profile_id": 2932, "is_prime": true}, {"legislator_profile_id": 2843, "is_prime": false}, {"legislator_profile_id": 2844, "is_prime": false}, {"legislator_profile_id": 2875, "is_prime": false}, {"legislator_profile_id": 2888, "is_prime": false}, {"legislator_profile_id": 2896, "is_prime": false}, {"legislator_profile_id": 2900, "is_prime": false}, {"legislator_profile_id": 2915, "is_prime": false}, {"legislator_profile_id": 2926, "is_prime": false}], "keywords": ["Administrative Rules", "Department of Social Services", "Public Health and Safety", "Public Welfare and Assistance"], "audio": [{"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-21T00:00:00-06:00", "committee": "HHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hhe27hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-22T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou28hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-26T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/she31hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-26T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/she31hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-26T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/she31hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-26T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/she31hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-02-26T00:00:00-06:00", "committee": "SHE", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/she31hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-04T00:00:00-06:00", "committee": "S", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/sen35hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-07T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou38hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-07T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou38hb1277a.mp3", "start_seconds": 0.0}, {"meeting_datetime": "2003-03-07T00:00:00-06:00", "committee": "H", "url": "https://sdpb.sd.gov/sdpbpodcast/2003/hou38hb1277a.mp3", "start_seconds": 0.0}], "bill_versions": [{"bill_id": 18282, "bill_version_id": 96492, "bill_version": "Introduced", "bill_version_date": "2003-02-04T10:31:03-06:00", "bill_text": "FOR AN ACT ENTITLED, An Act to create a medicaid pharmaceutical and therapeutics committee for the purpose of developing a preferred drug formulary. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: Section 1. There is created a medicaid pharmaceutical and therapeutics committee within the Department of Social Services for the purpose of developing a preferred drug formulary. The medicaid pharmaceutical and therapeutics committee shall consist of eleven members appointed by the Governor. Five members shall be physicians, licensed under chapter 36-4; five members shall be pharmacists licensed under chapter 36-11; and one member shall be a consumer representative. The members shall be appointed to serve for terms of two years. Members may be appointed to more than one term. The Department of Social Services shall serve as staff for the committee. The Governor shall ensure that at least some of the members of the medicaid pharmaceutical and therapeutics committee represent medicaid participating physicians and pharmacies serving all segments of the medicaid population, and have experience in either developing or practicing under a preferred drug formulary. At least one of the members shall represent the interests of pharmaceutical manufacturers. Committee members shall select a chair and a vice chair each year from the committee membership. Section 2. The committee shall meet at least quarterly and may meet at other times at the discretion of the chair. Section 3. Upon recommendation of the medicaid pharmaceutical and therapeutics committee, the Department of Social Services shall adopt a preferred drug list. To the extent feasible, the committee shall review all drug classes included in the formulary at least every twelve months, and may recommend additions to and deletions from the formulary, such that the formulary provides for medically appropriate drug therapies for medicaid patients and achieves cost savings. Section 4. The Department of Social Services shall publish and disseminate the preferred drug formulary to all medicaid providers in the state. Section 5. The medicaid pharmaceutical and therapeutics committee shall ensure that interested parties, including pharmaceutical manufacturers, have an opportunity to present public testimony to the committee with information or evidence supporting inclusion of a product on the preferred drug list. Such public testimony shall occur prior to any recommendations made by the committee for inclusion or exclusion from the preferred drug list. Upon timely notice, the Department of Social Services shall ensure that any drug that has been approved or had any of its particular uses approved by the United States Food and Drug Administration under a priority review classification will be reviewed by the medicaid pharmaceutical and therapeutics committee at the next regularly scheduled meeting. To the extent possible, upon notice by a manufacturer, the department shall also schedule a product review for any new product at the next regularly scheduled medicaid pharmaceutical and therapeutics committee. Section 6. The medicaid pharmaceutical and therapeutics committee shall develop its preferred drug list recommendations by considering the clinical efficacy, safety, and cost- effectiveness of a product. Section 7. The medicaid pharmaceutical and therapeutics committee may also make recommendations to the Department of Social Services regarding the prior authorization of any prescribed drug covered by medicaid. Section 8. Any medicaid recipient may appeal preferred drug formulary decisions using the fair hearing process administered by the Department of Social Services."}, {"bill_id": 18282, "bill_version_id": 97618, "bill_version": "House Health and Human Services Engrossed", "bill_version_date": "2003-02-21T12:48:57-06:00", "bill_text": "FOR AN ACT ENTITLED, An Act to create a pharmaceutical prior authorization program for eligible individuals receiving medical assistance pursuant to chapter 28-6. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: Section 1. The Legislature recognizes that outpatient prescription drugs are an essential component of patient care and, as a health benefits payer under the state's medical assistance program pursuant to chapter 28-6, the Legislature directs the Department of Social Services to establish a prior authorization program to ensure that beneficiaries have access to medically necessary medicines in a clinically appropriate and cost-effective manner. Section 2. A Medicaid Pharmaceutical and Therapeutics Committee is established within the Department of Social Services for the purpose of developing a pharmaceutical prior authorization program. The Medicaid Pharmaceutical and Therapeutics Committee shall consist of ten members appointed by the Governor. Five members shall be physicians licensed under chapter 36-4 and five members shall be pharmacists licensed under chapter 36-11. The members shall be appointed to serve for terms of three years. Members may be appointed to more than one term. The department shall serve as staff for the committee. The Governor shall ensure that at least some of the members of the Medicaid Pharmaceutical and Therapeutics Committee represent medicaid participating physicians and pharmacies serving all segments of the medicaid population, and have experience in either developing or practicing under a preferred drug formulary. Committee members shall select a chair and a vice chair each year from the committee membership. Section 3. The Medicaid Pharmaceutical and Therapeutics Committee shall meet at least three times each year in person and, in addition, the committee may meet as needed via teleconference or electronically. The chair shall arrange for meetings and the Department of Social Services shall mail out agendas and record committee minutes. Any decision of the committee requires an affirmative majority vote of the committee members. Any agenda item shall be requested thirty days prior to the scheduled committee meeting at which it will be heard. Any person not a member of the committee may attend a committee meeting at the discretion of the chair. Each member of the committee may receive per diem compensation and allowable expense reimbursement pursuant to \u00a7 4-7-10.4. Section 4. The Department of Social Services shall give notice of its intent to propose prior authorization requirements for prescription drugs and hold a public meeting regarding whether a certain drug or class of drugs shall require prior authorization. The department shall provide notice of the meeting at least thirty days prior to the meeting. Any interested party may provide information or recommendations, or both, related to the prior authorization of a drug. Section 5. The Medicaid Pharmaceutical and Therapeutics Committee shall develop its recommendations for the prior authorization program by considering the clinical efficacy, safety, and cost-effectiveness of a product. Section 6. The Medicaid Pharmaceutical and Therapeutics Committee shall: (1) Analyze and consider the recommendations of the interested parties and the potential impact of a decision to require prior authorization of a drug on the clinical care likely to be received by individuals covered under chapter 28-6; (2) Make recommendations to the Department of Social Services for the establishment and maintenance of an outpatient prescription drug prior authorization program; and (3) Review on at least an annual basis whether drugs placed on prior authorization are to remain on prior authorization. The department may accept or reject the recommendations provided by the committee and retains the authority to require prior authorization. The department shall post the list of drugs requiring prior authorization, together with any limits on coverage, on the department's website. Section 7. The prior authorization program shall meet the following conditions: (1) The program shall provide telephone, facsimile, or other electronically transmitted approval or denial within twenty-four hours after receipt of the prior authorization request; (2) In an emergency situation, including a situation in which a response to a prior authorization request is unavailable, a seventy-two hour supply of the prescribed drug shall be dispensed and paid for by the medical assistance program or, at the discretion of the department, a supply greater than seventy-two hours that will assure a minimum effective duration of therapy for an acute intervention; (3) Authorization shall be granted if the drug is prescribed for a medically accepted use supported by either the compendia, approved product labeling, or peer-reviewed literature unless there is a therapeutically equivalent drug that is available without prior authorization; and (4) The department shall consult with prescribers to develop a streamlined process for the prescriber to furnish any documentation required to support a prior authorization request, including the name, title, address, and telephone number of the prescriber making the request, date of the request, the product name of the requested drug, a description of the circumstances and basis for the request, and whether the request is an emergency. Section 8. Any policies or procedures regarding the prior authorization program adopted by the Department of Social Services pursuant to this Act are exempt from the Administrative Procedures Act established in chapter 1-26."}, {"bill_id": 18282, "bill_version_id": 97746, "bill_version": "House Engrossed", "bill_version_date": "2003-02-22T17:15:40-06:00", "bill_text": "FOR AN ACT ENTITLED, An Act to create a pharmaceutical prior authorization program for eligible individuals receiving medical assistance pursuant to chapter 28-6. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: Section 1. The Legislature recognizes that outpatient prescription drugs are an essential component of patient care and, as a health benefits payer under the state's medical assistance program pursuant to chapter 28-6, the Legislature directs the Department of Social Services to establish a prior authorization program to ensure that beneficiaries have access to medically necessary medicines in a clinically appropriate and cost-effective manner. Section 2. A Medicaid Pharmaceutical and Therapeutics Committee is established within the Department of Social Services for the purpose of developing a pharmaceutical prior authorization program. The Medicaid Pharmaceutical and Therapeutics Committee shall consist of ten members appointed by the Governor. Five members shall be physicians licensed under chapter 36-4 and five members shall be pharmacists licensed under chapter 36-11. The members shall be appointed to serve for terms of three years. Members may be appointed to more than one term. The department shall serve as staff for the committee. The Governor shall ensure that at least some of the members of the Medicaid Pharmaceutical and Therapeutics Committee represent medicaid participating physicians and pharmacies serving all segments of the medicaid population, and have experience in either developing or practicing under a preferred drug formulary. Committee members shall select a chair and a vice chair each year from the committee membership. Section 3. The Medicaid Pharmaceutical and Therapeutics Committee shall meet at least three times each year in person and, in addition, the committee may meet as needed via teleconference or electronically. The chair shall arrange for meetings and the Department of Social Services shall mail out agendas and record committee minutes. Any decision of the committee requires an affirmative majority vote of the committee members. Any agenda item shall be requested thirty days prior to the scheduled committee meeting at which it will be heard. Any person not a member of the committee may attend a committee meeting at the discretion of the chair. Each member of the committee may receive per diem compensation and allowable expense reimbursement pursuant to \u00a7 4-7-10.4. Section 4. The Department of Social Services shall give notice of its intent to propose prior authorization requirements for prescription drugs and hold a public meeting regarding whether a certain drug or class of drugs shall require prior authorization. The department shall provide notice of the meeting at least thirty days prior to the meeting. Any interested party may provide information or recommendations, or both, related to the prior authorization of a drug. Section 5. The Medicaid Pharmaceutical and Therapeutics Committee shall develop its recommendations for the prior authorization program by considering the clinical efficacy, safety, and cost-effectiveness of a product. Section 6. The Medicaid Pharmaceutical and Therapeutics Committee shall: (1) Analyze and consider the recommendations of the interested parties and the potential impact of a decision to require prior authorization of a drug on the clinical care likely to be received by individuals covered under chapter 28-6; (2) Make recommendations to the Department of Social Services for the establishment and maintenance of an outpatient prescription drug prior authorization program; and (3) Review on at least an annual basis whether drugs placed on prior authorization are to remain on prior authorization. The department may accept or reject the recommendations provided by the committee and retains the authority to require prior authorization. The department shall post the list of drugs requiring prior authorization, together with any limits on coverage, on the department's website. Section 7. The prior authorization program shall meet the following conditions: (1) The program shall provide telephone, facsimile, or other electronically transmitted approval or denial within twenty-four hours after receipt of the prior authorization request; (2) In an emergency situation, including a situation in which a response to a prior authorization request is unavailable, a seventy-two hour supply of the prescribed drug shall be dispensed and paid for by the medical assistance program or, at the discretion of the department, a supply greater than seventy-two hours that will assure a minimum effective duration of therapy for an acute intervention; (3) Authorization shall be granted if the drug is prescribed for a medically accepted use supported by either the compendia, approved product labeling, or peer-reviewed literature unless there is a therapeutically equivalent drug that is available without prior authorization; and (4) The department shall consult with prescribers to develop a streamlined process for the prescriber to furnish any documentation required to support a prior authorization request, including the name, title, address, and telephone number of the prescriber making the request, date of the request, the product name of the requested drug, a description of the circumstances and basis for the request, and whether the request is an emergency. Section 8. Nothing in this Act imposes any restrictions or limitations on the availability of medications prescribed for the treatment of mental illness."}, {"bill_id": 18282, "bill_version_id": 97983, "bill_version": "Senate Health and Human Services Engrossed", "bill_version_date": "2003-02-26T13:34:49-06:00", "bill_text": "FOR AN ACT ENTITLED, An Act to create a pharmaceutical prior authorization program for eligible individuals receiving medicaid. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF SOUTH DAKOTA: Section 1. The Legislature recognizes that outpatient prescription drugs are an essential component of patient care and, as a health benefits payer under the state's medical assistance program pursuant to chapter 28-6, the Legislature directs the Department of Social Services to establish a prior authorization program to ensure that beneficiaries have access to medically necessary medicines in a clinically appropriate and cost-effective manner. Section 2. A Medicaid Pharmaceutical and Therapeutics Committee is established within the Department of Social Services for the purpose of developing a pharmaceutical prior authorization program. The Medicaid Pharmaceutical and Therapeutics Committee shall consist of ten members appointed by the Governor. Five members shall be physicians licensed under chapter 36-4, one of whom is a psychiatrist, and five members shall be pharmacists licensed under chapter 36-11. The members shall be appointed to serve for terms of three years. Members may be appointed to more than one term. The department shall serve as staff for the committee. The Governor shall ensure that at least some of the members of the Medicaid Pharmaceutical and Therapeutics Committee represent medicaid participating physicians and pharmacies serving all segments of the medicaid population, and have experience in either developing or practicing under a preferred drug formulary. Committee members shall select a chair and a vice chair each year from the committee membership. Section 3. The Medicaid Pharmaceutical and Therapeutics Committee shall meet at least three times each year in person and, in addition, the committee may meet as needed via teleconference or electronically. The chair shall arrange for meetings and the Department of Social Services shall mail out agendas and record committee minutes. Any decision of the committee requires an affirmative majority vote of the committee members. Any agenda item shall be requested thirty days prior to the scheduled committee meeting at which it will be heard. Any person not a member of the committee may attend a committee meeting at the discretion of the chair. Each member of the committee may receive per diem compensation and allowable expense reimbursement pursuant to \u00a7 4-7-10.4. Section 4. The Department of Social Services shall give notice of its intent to propose prior authorization requirements for prescription drugs and hold a public meeting regarding whether a certain drug or class of drugs shall require prior authorization. The department shall provide notice of the meeting at least thirty days prior to the meeting. Any interested party may provide information or recommendations, or both, related to the prior authorization of a drug. Section 5. The Medicaid Pharmaceutical and Therapeutics Committee shall develop its recommendations for the prior authorization program by considering the clinical efficacy, safety, and cost-effectiveness of a product. Section 6. The Medicaid Pharmaceutical and Therapeutics Committee shall: (1) Analyze and consider the recommendations of the interested parties and the potential impact of a decision to require prior authorization of a drug on the clinical care likely to be received by individuals covered under chapter 28-6; (2) Make recommendations to the Department of Social Services for the establishment and maintenance of an outpatient prescription drug prior authorization program; and (3) Review on at least an annual basis whether drugs placed on prior authorization are to remain on prior authorization. The department may accept or reject the recommendations provided by the committee and retains the authority to require prior authorization. The department shall post the list of drugs requiring prior authorization, together with any limits on coverage, on the department's website. Section 7. The prior authorization program shall meet the following conditions: (1) The program shall provide telephone, facsimile, or other electronically transmitted approval or denial within twenty-four hours after receipt of the prior authorization request; (2) In an emergency situation, including a situation in which a response to a prior authorization request is unavailable, a seventy-two hour supply of the prescribed drug shall be dispensed and paid for by the medical assistance program or, at the discretion of the department, a supply greater than seventy-two hours that will assure a minimum effective duration of therapy for an acute intervention; (3) Authorization shall be granted if the drug is prescribed for a medically accepted use supported by either the compendia, approved product labeling, or peer-reviewed literature unless there is a therapeutically equivalent drug that is available without prior authorization; and (4) The department shall consult with prescribers to develop a streamlined process for the prescriber to furnish any documentation required to support a prior authorization request, including the name, title, address, and telephone number of the prescriber making the request, date of the request, the product name of the requested drug, a description of the circumstances and basis for the request, and whether the request is an emergency."}], "amendments": [], "fiscal_notes": [], "action_log": [{"bill_id": 18282, "action_date": "2003-02-04T14:00:00-06:00", "document_id": 96525, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/96525.pdf", "status_text": "First read in House and referred to", "journal_page": 292, "committee_id_action": 798, "committee_id_assigned": 789, "result": "N", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-21T07:45:00-06:00", "document_id": 97599, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97599.pdf", "status_text": "Hog Housed", "journal_page": null, "committee_id_action": 789, "committee_id_assigned": null, "result": "D", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-21T07:45:00-06:00", "document_id": 97599, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97599.pdf", "status_text": "Hog Housed", "journal_page": null, "committee_id_action": 789, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-21T07:45:00-06:00", "document_id": 97599, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97599.pdf", "status_text": "Do Pass Amended,", "journal_page": 515, "committee_id_action": 789, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 54891, "president_vote": null, "Yea": [2843, 2862, 2872, 2888, 2896, 2900, 2915, 2930, 2933, 2859, 2932], "Nay": [2871], "Excused": [2934]}}, {"bill_id": 18282, "action_date": "2003-02-21T07:45:00-06:00", "document_id": 97599, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97599.pdf", "status_text": "Title Amended", "journal_page": null, "committee_id_action": 789, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-21T07:45:00-06:00", "document_id": 97599, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97599.pdf", "status_text": "Scheduled for Committee hearing on this date", "journal_page": null, "committee_id_action": 789, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-22T14:00:00-06:00", "document_id": 97757, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97757.pdf", "status_text": "Motion to Amend,", "journal_page": 572, "committee_id_action": 798, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 56730, "president_vote": null, "Yea": [2833, 2836, 2837, 2839, 2841, 2842, 2845, 2846, 2855, 2858, 2861, 2862, 2863, 2864, 2866, 2869, 2870, 2871, 2873, 2874, 2877, 2879, 2885, 2889, 2890, 2894, 2896, 2902, 2905, 2907, 2909, 2913, 2914, 2919, 2920, 2923, 2924, 2925, 2929, 2930, 2931, 2933, 2934, 2937, 2899], "Nay": [2843, 2844, 2848, 2859, 2860, 2872, 2875, 2888, 2892, 2893, 2895, 2898, 2900, 2906, 2911, 2912, 2915, 2917, 2922, 2932, 2936, 2938], "Excused": [2857, 2884, 2910]}}, {"bill_id": 18282, "action_date": "2003-02-22T14:00:00-06:00", "document_id": 97757, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97757.pdf", "status_text": "Motion to Amend,", "journal_page": 572, "committee_id_action": 798, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-22T14:00:00-06:00", "document_id": 97757, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97757.pdf", "status_text": "Do Pass Amended,", "journal_page": 573, "committee_id_action": 798, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 56731, "president_vote": null, "Yea": [2833, 2836, 2837, 2839, 2841, 2842, 2843, 2844, 2845, 2846, 2848, 2855, 2858, 2859, 2860, 2861, 2862, 2864, 2866, 2869, 2870, 2871, 2872, 2873, 2874, 2875, 2879, 2884, 2888, 2889, 2890, 2892, 2893, 2895, 2896, 2898, 2900, 2902, 2905, 2906, 2907, 2909, 2910, 2911, 2912, 2913, 2914, 2915, 2917, 2920, 2923, 2924, 2929, 2930, 2931, 2932, 2933, 2934, 2936, 2937, 2938], "Excused": [2857], "Nay": [2863, 2877, 2885, 2894, 2919, 2922, 2925, 2899]}}, {"bill_id": 18282, "action_date": "2003-02-24T14:00:00-06:00", "document_id": 97823, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97823.pdf", "status_text": "First read in Senate and referred to", "journal_page": 582, "committee_id_action": 799, "committee_id_assigned": 776, "result": "N", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-26T10:00:00-06:00", "document_id": 97966, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97966.pdf", "status_text": "Do Pass Amended,", "journal_page": 608, "committee_id_action": 776, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 55121, "president_vote": null, "Yea": [2840, 2849, 2868, 2916, 2926, 2908, 2834]}}, {"bill_id": 18282, "action_date": "2003-02-26T10:00:00-06:00", "document_id": 97966, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97966.pdf", "status_text": "Title Amended", "journal_page": null, "committee_id_action": 776, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-26T10:00:00-06:00", "document_id": 97966, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/97966.pdf", "status_text": "Scheduled for Committee hearing on this date", "journal_page": null, "committee_id_action": 776, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 18282, "action_date": "2003-02-28T13:00:00-06:00", "document_id": 98160, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98160.pdf", "status_text": "Deferred to another day", "journal_page": 651, "committee_id_action": 799, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-03-03T14:00:00-06:00", "document_id": 98282, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98282.pdf", "status_text": "Deferred to another day", "journal_page": 672, "committee_id_action": 799, "committee_id_assigned": null, "result": "P", "vote": {}}, {"bill_id": 18282, "action_date": "2003-03-04T14:00:00-06:00", "document_id": 98360, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98360.pdf", "status_text": "Do Pass Amended,", "journal_page": 700, "committee_id_action": 799, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 55398, "president_vote": null, "Yea": [2832, 2834, 2835, 2838, 2840, 2849, 2850, 2851, 2852, 2853, 2854, 2865, 2868, 2876, 2878, 2880, 2881, 2882, 2883, 2886, 2887, 2891, 2897, 2901, 2903, 2908, 2916, 2926, 2927, 2928, 2935], "Nay": [2847, 2856, 2904, 2921]}}, {"bill_id": 18282, "action_date": "2003-03-06T14:00:00-06:00", "document_id": 98515, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98515.pdf", "status_text": "Conference Committee appointments", "journal_page": 737, "committee_id_action": 799, "committee_id_assigned": null, "result": "N", "vote": {}}, {"bill_id": 18282, "action_date": "2003-03-07T09:00:00-06:00", "document_id": 98582, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98582.pdf", "status_text": "Conference Committee Report adopted", "journal_page": 794, "committee_id_action": 798, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 56900, "president_vote": null, "Yea": [2833, 2836, 2837, 2839, 2841, 2842, 2843, 2844, 2845, 2846, 2848, 2855, 2858, 2859, 2860, 2861, 2862, 2863, 2864, 2866, 2869, 2870, 2871, 2872, 2873, 2874, 2875, 2877, 2879, 2884, 2885, 2888, 2889, 2890, 2892, 2893, 2894, 2896, 2898, 2900, 2902, 2905, 2906, 2907, 2909, 2910, 2911, 2912, 2913, 2917, 2919, 2920, 2922, 2923, 2924, 2925, 2930, 2931, 2932, 2933, 2934, 2936, 2937, 2938, 2899], "Nay": [2857, 2895, 2915, 2929], "Excused": [2914]}}, {"bill_id": 18282, "action_date": "2003-03-07T09:00:00-06:00", "document_id": 98533, "document_url": "https://mylrc.sdlegislature.gov/api/Documents/98533.pdf", "status_text": "Conference Committee Report adopted", "journal_page": 772, "committee_id_action": 799, "committee_id_assigned": null, "result": "P", "vote": {"vote_id": 55497, "president_vote": null, "Yea": [2832, 2835, 2838, 2840, 2849, 2851, 2852, 2853, 2854, 2856, 2865, 2876, 2878, 2880, 2882, 2883, 2886, 2887, 2891, 2897, 2903, 2904, 2908, 2921, 2926, 2927, 2928], "Nay": [2834, 2847, 2868, 2881, 2901, 2916, 2935], "Excused": [2850]}}]}